Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects [Phase 2]

View source ↗

Summary

Phase 2 study evaluating SM04690 injected into the knee for osteoarthritis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• SM04690 (SM04690)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2020-09-16